Literature DB >> 25459601

Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy.

Michael D Nelson, Lidia S Szczepaniak, Troy M LaBounty, Edward Szczepaniak, Debiao Li, Mourad Tighiouart, Quanlin Li, Rohan Dharmakumar, Gregg Sannes, Zhaoyang Fan, Roya Yumul, W David Hardy, Antonio Hernandez Conte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25459601      PMCID： PMC5689079          DOI： 10.1016/j.jcmg.2014.04.024

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  5 in total

Review 1.  Epidemiological and clinical aspects of the metabolic complications of HIV infection the fat redistribution syndrome.

Authors:  C A Wanke
Journal:  AIDS       Date:  1999-07-30       Impact factor: 4.177

2.  Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study.

Authors:  Michael D Nelson; Lidia S Szczepaniak; Janet Wei; Afsaneh Haftabaradaren; Meghan Bharadwaj; Behzad Sharif; Puja Mehta; Xiao Zhang; Louise E Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-14       Impact factor: 7.792

3.  Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging.

Authors:  Michael D Nelson; Ronald G Victor; Edward W Szczepaniak; Vinaya Simha; Abhimanyu Garg; Lidia S Szczepaniak
Journal:  Am J Cardiol       Date:  2013-06-22       Impact factor: 2.778

4.  HAART drugs induce mitochondrial damage and intercellular gaps and gp120 causes apoptosis.

Authors:  Milan Fiala; Thomas Murphy; James MacDougall; Wendy Yang; Alfonso Luque; Luisa Iruela-Arispe; John Cashman; Georgette Buga; Russel E Byrns; Giuseppe Barbaro; James Arthos
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

5.  Acute myocardial infarction in patients infected with human immunodeficiency virus.

Authors:  Philip Varriale; Gonzalo Saravi; Eliezer Hernandez; Francisco Carbon
Journal:  Am Heart J       Date:  2004-01       Impact factor: 4.749
  5 in total
  14 in total

Review 1.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 2.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

3.  Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus.

Authors:  Markella V Zanni; Magid Awadalla; Mabel Toribio; Jake Robinson; Lauren A Stone; Diana Cagliero; Adam Rokicki; Connor P Mulligan; Jennifer E Ho; Anne M Neilan; Mark J Siedner; Virginia A Triant; Takara L Stanley; Lidia S Szczepaniak; Michael Jerosch-Herold; Michael D Nelson; Tricia H Burdo; Tomas G Neilan
Journal:  J Infect Dis       Date:  2020-03-28       Impact factor: 5.226

4.  Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.

Authors:  Tomas G Neilan; Kim-Lien Nguyen; Vlad G Zaha; Kara W Chew; Leavitt Morrison; Ntobeko A B Ntusi; Mabel Toribio; Magid Awadalla; Zsofia D Drobni; Michael D Nelson; Tricia H Burdo; Marije Van Schalkwyk; Paul E Sax; Daniel J Skiest; Karen Tashima; Raphael J Landovitz; Eric Daar; Alysse G Wurcel; Gregory K Robbins; Robert K Bolan; Kathleen V Fitch; Judith S Currier; Gerald S Bloomfield; Patrice Desvigne-Nickens; Pamela S Douglas; Udo Hoffmann; Steven K Grinspoon; Heather Ribaudo; Rodney Dawson; Matthew Bidwell Goetz; Mamta K Jain; Alberta Warner; Lidia S Szczepaniak; Markella V Zanni
Journal:  J Infect Dis       Date:  2020-07-09       Impact factor: 5.226

Review 5.  Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations.

Authors:  Mabel Toribio; Tomas G Neilan; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

Review 6.  Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population.

Authors:  Arjun Sinha; Matthew J Feinstein
Journal:  Curr HIV/AIDS Rep       Date:  2021-01-12       Impact factor: 5.071

7.  Abnormal Myocardial Function Is Related to Myocardial Steatosis and Diffuse Myocardial Fibrosis in HIV-Infected Adults.

Authors:  Diana K Thiara; Chia Ying Liu; Fabio Raman; Sabrina Mangat; Julia B Purdy; Horacio A Duarte; Nancyanne Schmidt; Jamie Hur; Christopher T Sibley; David A Bluemke; Colleen Hadigan
Journal:  J Infect Dis       Date:  2015-05-11       Impact factor: 5.226

8.  Intramyocardial Triglycerides Among Women With vs Without HIV: Hormonal Correlates and Functional Consequences.

Authors:  Mabel Toribio; Tomas G Neilan; Magid Awadalla; Lauren A Stone; Adam Rokicki; Corinne Rivard; Connor P Mulligan; Diana Cagliero; Lindsay T Fourman; Takara L Stanley; Jennifer E Ho; Virginia A Triant; Tricia H Burdo; Michael D Nelson; Lidia S Szczepaniak; Markella V Zanni
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

9.  Cocaine use may modify HIV/ART-associated myocardial steatosis and hepatic steatosis.

Authors:  Shenghan Lai; Gary Gerstenblith; Richard D Moore; David D Celentano; David A Bluemke; Glenn Treisman; Chia-Ying Liu; Ji Li; Shaoguang Chen; Thomas Kickler; Hong Lai
Journal:  Drug Alcohol Depend       Date:  2017-05-26       Impact factor: 4.492

10.  Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.

Authors:  Raza M Alvi; Anne M Neilan; Noor Tariq; Magid Awadalla; Maryam Afshar; Dahlia Banerji; Adam Rokicki; Connor Mulligan; Virginia A Triant; Markella V Zanni; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-07-31       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.